| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.067 | 0.2 |